Impact and Influence of the Use of Hypnosis Adapted to People With Severe Stage Neurocognitive Disorder (HAPNeSS) on the Professional Practices of EHPAD (Establishment for Dependent Elderly People) Caregivers With Elderly Residents

NCT06535763 | Not Yet Recruiting

• 1 other identifier: CHUBX 2023/87
• Study Type: observational
• Target: 36
• Locations: 1 country
• Sites: 1

Brief Summary

The aim of this study is to propose a non-anxiety-inducing method of managing behavioral disorders for patients and healthcare professionals. The main objective of this study is to evaluate the implementation, use and effects of HAPNeSS (Hypnosis Adapted to People with Severe Neurocognitive Disorders) training on the management of residents aged over 75 with moderately severe to severe Alzheimer's disease or a related disorder, who may present behavioral disorders, with caregivers working in EHPAD.

Conditions

Alzheimer Disease; Behavior Disorders

Keywords

self-hypnosis; formation; seniors

Outcome Measures

Primary Outcomes (1)

• Impact of HAPNeSS on the management of work situations involving behavioral disorders.

  Number of work situations which the carer feels he/she has had difficulty managing, involving a resident with a neurocognitive disorder and behavioural problems.

  Month 2 and month 6

Secondary Outcomes (1)

• Effects of HAPNeSS method to professional practices

  Month 2 and month 6

Study Arms (1)

professional caregiver

nurse, care assistant, gerontological care assistant, psychologist, coordinating doctor, psychomotrician, occupational therapist in one of the 3 EHPADs in the study

Other: professional caregiver

Interventions

professional caregiver OTHER

Care professionals will be questioned using a self-administered Quality of Life at Work scale, as well as a second scale (before and after training, with one test per day for 3 consecutive working days) asking about the number of work situations involving behavioral disorders in the residents under their care, and how they use the HAPNeSS method to deal with these situations. The effects of the HAPNeSS method on caregivers' professional practices (actions taken, performance of tasks, relations with residents, etc.) and their feelings on the subject, will be collected in two semi-structured interviews (with half the participants selected at random) conducted before and after the training course by the research team's occupational psychologist.

professional caregiver

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

EHPAD staff meeting : * Nurses, care assistants, gerontological care assistants, psychologists, coordinating physicians, psychomotor therapists, occupational therapists; with more than one year's experience in the structure.

You may qualify if:

• EHPAD staff meeting the following criteria will be included in the study:
• Nurses, care assistants, gerontological care assistants, psychologists, coordinating physicians, psychomotor therapists, occupational therapists;
• More than one year's experience in the structure.
• The study will examine the individual perceptions of EHPAD professionals of patients meeting the following criteria:
• Be a resident of an EHPAD ;
• suffering from a moderately severe or severe major neurocognitive disorder;
• over 75 years of age.

You may not qualify if:

• EHPAD professionals will not be included:
• Not fluent in French,
• Not wishing to be trained in hypnosis.
• The individual perception of EHPAD professionals of patients meeting these criteria will not be questioned in the study:
• Minor neurocognitive impairment, major neurocognitive impairment at a mild or moderate stage, or no cognitive impairment;
• under 75 years of age.

Sponsors & Collaborators

• University Hospital, Bordeaux: lead

Study Sites (1)

Chu de Bordeaux

Pessac, France

Location

MeSH Terms

Conditions

Alzheimer Disease; Mental Disorders

Condition Hierarchy (Ancestors)

Dementia; Brain Diseases; Central Nervous System Diseases; Nervous System Diseases; Tauopathies; Neurodegenerative Diseases; Neurocognitive Disorders

Study Officials

• Marie FLOCCIA, MD

  University Hospital, Bordeaux

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Marie FLOCCIA, MD

CONTACT

+33556795679; marie.floccia@chu-bordeaux.fr

Emma SALANNE

CONTACT

+33556795679; emma.salanne@chu-bordeaux.fr

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: July 23, 2024
• First Posted: August 2, 2024
• Study Start: September 1, 2024
• Primary Completion: March 1, 2025
• Study Completion: March 1, 2025
• Last Updated: August 2, 2024

Record last verified: 2024-07

Data Sharing

• IPD Sharing: Will not share

Locations

FR (1)